agilon health, inc. Income Tax Expense
agilon health, inc. (AGL) reported Income Tax Expense of -$375.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-05
- agilon health, inc. income tax expense (benefit) for the quarter ending 2026-06-30 was -$375.00K, a 704.84% decline year-over-year.
- agilon health, inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $28.00K, a 85.71% decline year-over-year.
- agilon health, inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $1.32M, a 24.64% decline year-over-year.
- agilon health, inc. income tax expense (benefit) for the quarter ending 2025-09-30 was -$331.00K.
- agilon health, inc. income tax expense (benefit) for fiscal 2025 was $1.25M, a 13.78% decline from fiscal 2024.
- agilon health, inc. income tax expense (benefit) for fiscal 2024 was $1.45M, a 83.44% increase from fiscal 2023.
- agilon health, inc. income tax expense (benefit) for fiscal 2023 was $791.00K, a 51.77% decline from fiscal 2022.
- agilon health, inc. income tax expense (benefit) for fiscal 2022 was $1.64M, a 85.10% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$375.00K 10-Q · filed 2026-08-05 | -$347.00K 10-Q · filed 2026-08-05 | $977.00K derived: sum of 3 quarters · filed 2026-08-05 | $646.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-06 | $1.35M derived: sum of 2 quarters · filed 2026-05-06 | $1.02M derived: sum of 3 quarters · filed 2026-05-06 | $1.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $993.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.05M derived: sum of 3 quarters · filed 2026-08-05 | $1.25M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$331.00K 10-Q · filed 2025-11-04 | -$269.00K derived: sum of 2 quarters · filed 2026-08-05 | -$73.00K 10-Q · filed 2025-11-04 | $1.68M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $62.00K 10-Q · filed 2026-08-05 | $258.00K 10-Q · filed 2026-08-05 | $2.02M derived: sum of 3 quarters · filed 2026-08-05 | $1.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $196.00K 10-Q · filed 2026-05-06 | $1.95M derived: sum of 2 quarters · filed 2026-05-06 | $1.36M derived: sum of 3 quarters · filed 2026-05-06 | $1.78M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.17M derived: sum of 2 quarters · filed 2026-02-25 | $1.58M derived: sum of 3 quarters · filed 2026-02-25 | $1.45M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$590.00K 10-Q · filed 2025-11-04 | -$173.00K derived: sum of 2 quarters · filed 2025-11-04 | -$306.00K 10-Q · filed 2025-11-04 | -$39.00K derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $417.00K 10-Q · filed 2025-08-04 | $284.00K 10-Q · filed 2025-08-04 | $551.00K derived: sum of 3 quarters · filed 2026-02-25 | $1.76M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$133.00K 10-Q · filed 2025-05-06 | $134.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.34M derived: sum of 3 quarters · filed 2026-02-25 | $2.42M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $267.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.48M derived: sum of 2 quarters · filed 2026-02-25 | $2.55M derived: sum of 3 quarters · filed 2026-02-25 | $791.00K 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.21M 10-Q · filed 2024-11-07 | $2.28M derived: sum of 2 quarters · filed 2024-11-07 | $524.00K 10-Q · filed 2024-11-07 | $1.10M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $1.07M 10-Q · filed 2024-08-06 | -$686.00K 10-Q · filed 2024-08-06 | -$114.00K derived: sum of 3 quarters · filed 2025-02-25 | $445.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$1.76M 10-Q · filed 2024-05-07 | -$1.19M derived: sum of 2 quarters · filed 2025-02-25 | -$628.00K derived: sum of 3 quarters · filed 2025-02-25 | -$48.00K derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $1.13M derived: sum of 2 quarters · filed 2025-02-25 | $1.71M derived: sum of 3 quarters · filed 2025-02-25 | $1.64M 10-K · filed 2025-02-25 |
| 2022-09-30 | $559.00K 10-Q · filed 2023-11-02 | $1.14M derived: sum of 2 quarters · filed 2023-11-02 | $1.07M 10-Q · filed 2023-11-02 | $1.25M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $580.00K 10-Q · filed 2023-08-03 | $509.00K 10-Q · filed 2023-08-03 | $688.00K derived: sum of 3 quarters · filed 2024-02-27 | $944.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$71.00K 10-Q · filed 2023-05-09 | $108.00K derived: sum of 2 quarters · filed 2024-02-27 | $364.00K derived: sum of 3 quarters · filed 2024-02-27 | $799.00K derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $435.00K derived: sum of 2 quarters · filed 2024-02-27 | $870.00K derived: sum of 3 quarters · filed 2024-02-27 | $886.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | $256.00K 10-Q · filed 2022-11-03 | $691.00K derived: sum of 2 quarters · filed 2022-11-03 | $707.00K 10-Q · filed 2022-11-03 | $1.50M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $435.00K 10-Q · filed 2022-08-04 | $451.00K 10-Q · filed 2022-08-04 | $1.24M derived: sum of 3 quarters · filed 2023-03-01 | $1.28M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $16.00K 10-Q · filed 2022-05-05 | $807.00K derived: sum of 2 quarters · filed 2023-03-01 | $842.00K derived: sum of 3 quarters · filed 2023-03-01 | $881.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $791.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $826.00K derived: sum of 2 quarters · filed 2023-03-01 | $865.00K derived: sum of 3 quarters · filed 2023-03-01 | $865.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $35.00K 10-Q · filed 2021-10-28 | $74.00K derived: sum of 2 quarters · filed 2021-10-28 | $74.00K 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $39.00K 10-Q · filed 2021-08-04 | $39.00K 10-Q · filed 2021-08-04 | ||
| 2019-12-31 | -$232.00K 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |